Welcome to our dedicated page for B. Riley Financial news (Ticker: RILY), a resource for investors and traders seeking the latest updates and insights on B. Riley Financial stock.
B. Riley Financial, Inc. (NASDAQ: RILY) provides integrated financial solutions across investment banking, wealth management, and corporate advisory services. This dedicated news hub aggregates all essential updates about the company's operations, strategic initiatives, and market position.
Investors and analysts will find timely information on earnings announcements, mergers & acquisitions, leadership changes, and strategic partnerships. The curated collection includes press releases, regulatory filings, and third-party analysis to support informed decision-making.
Key coverage areas include capital market activities, restructuring developments, wealth management expansions, and financial consulting projects. Regular updates ensure stakeholders maintain current awareness of RILY's cross-platform initiatives in North American and European markets.
Bookmark this page for convenient access to verified RILY updates. Combine real-time alerts with historical context to track the company's evolving financial strategies and industry impact.
B. Riley Financial (NASDAQ: RILY) has released preliminary Q4 2024 financial estimates, projecting net income available to common shareholders between $48 million to $68 million, or $1.57 to $2.22 per diluted share. This includes approximately $236-247 million income from discontinued operations related to Great American businesses divesture.
The company reports a net loss from continuing operations of ($178) million to ($187) million, impacted by goodwill impairment charges of $73-79 million and $49 million in trading and investment losses. Operating adjusted EBITDA from continuing operations is estimated at $12-14 million.
As of December 31, 2024, B. Riley held $257 million in cash and restricted cash, with total debt of $1.78 billion. The company has reduced debt by over $700 million since January 2024 and retired its Nomura facility. The final audited results are due March 17, 2025.
B. Riley Financial (NASDAQ: RILY) has announced the completion of redemption procedures for all outstanding 6.375% Senior Notes due February 28, 2025 (NASDAQ: RILYM). The notes were redeemed at 100% of their principal amount, plus accrued and unpaid interest on the redemption date of February 28, 2025. Following the redemption, the Notes have ceased trading on NASDAQ.
B. Riley Financial (NASDAQ: RILY) has secured a new $160 million senior secured debt facility from Oaktree Capital Management. The company used $118 million to retire its Nomura Senior Secured Credit Agreement, with the remaining funds allocated for working capital, including up to $35 million for its participation in JOANN's liquidation joint venture.
Through GA Group, in which B. Riley holds a 44% stake, the company will serve as JOANN's exclusive liquidation agent for all 790 store locations, managing approximately $2 billion in retail inventory. The liquidation is expected to complete in 12 weeks.
The new three-year facility terms include an interest rate of three-month SOFR plus 8.00%. Additionally, B. Riley issued warrants to Oaktree to purchase 1,832,290 common shares (6% of outstanding stock) at $5.14 per share, representing a 20% premium to the 30-day VWAP.
B. Riley Financial (NASDAQ: RILY) has successfully regained compliance with Nasdaq Listing Rule 5250(c)(1) following the filing of its Third Quarter 10-Q. The company received confirmation from The Nasdaq Stock Market on February 24, 2025, verifying its return to compliance status. This listing rule specifically mandates that listed companies must file all required periodic reports with the Securities and Exchange Commission in a timely manner.
B. Riley Financial (NASDAQ: RILY) has announced it will release preliminary Q4 2024 financial results after market close on March 3, 2025, followed by an investor conference call at 4:30 p.m. ET. The company has filed its Q3 2024 Form 10-Q and expects to regain compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports.
During the upcoming conference call, management plans to provide a comprehensive business update, discuss priorities for the coming year, and outline capital allocation strategies focused on growth and value creation.
B. Riley Securities has announced its upcoming Precision Oncology & Radiopharma Investor Conference, scheduled for February 28, 2025, in New York. The one-day event will showcase over 30 companies focused on next-generation targeted oncology and radiopharmaceutical therapeutics and diagnostics.
The conference will feature research analyst-moderated panels discussing healthcare policy disruptions, radiopharma value chain developments, antibody drug conjugates, T-cell engagers, and synthetic lethality approaches. These emerging modalities have been significant targets in recent pharmaceutical acquisitions.
According to Andy Moore, CEO of B. Riley Securities, the conference brings together industry leaders developing breakthrough therapies, offering investors opportunities to participate in healthcare advancement. The event format includes panels, presentations, fireside chats, and roundtables, with attendance being invitation-only. Interested parties can register by emailing BRSHealthcareEvents@brileyfin.com.
B. Riley Securities has announced its 25th Annual Investor Conference, scheduled for May 21-22, 2025, at the Ritz-Carlton, Marina Del Rey in California. The premier West Coast event will feature approximately 200 public companies presenting to over 1,000 attendees including institutional, private equity, and venture capital investors.
The two-day conference will include research analyst-moderated executive roundtables, fireside chats, thematic industry panel discussions, and one-on-one meetings with corporate management teams. CEO Andy Moore emphasized the conference's role in creating value for clients and maintaining long-standing partnerships.
The event is invitation-only, with B. Riley's award-winning equity research team curating a mix of new and established companies. Interested parties can request invitations via email at 1on1@brileyfin.com, while sponsorship inquiries should be directed to conference@brileyfin.com.
B. Riley Financial (NASDAQ: RILY) has filed its Q2 2024 Form 10-Q, with financial statements matching preliminary results released on August 12, 2024. The company disclosed a preliminary cash balance of $257 million as of December 31, 2024, which includes reserves for February 2025 Senior Notes payment.
The company acknowledged delays in financial filings due to significant events in 2024 and expects to file Q3 2024 report soon to regain Nasdaq compliance. Management indicates plans to retire February 2025 Senior Notes as scheduled and reports taking actions to monetize non-core assets and deleverage the balance sheet. The company maintains strong net capital levels in its broker dealer and anticipates capitalizing on expected recovery in small- and mid-cap equity markets.
B. Riley Financial (NASDAQ: RILY) received an additional delinquency notification from Nasdaq on November 20, 2024, for non-compliance with listing rules due to delayed filing of Quarterly Reports for periods ended June 30 and September 30, 2024. While this notification doesn't immediately affect the company's Nasdaq listing, B. Riley must submit an updated compliance plan by December 5, 2024. If accepted, Nasdaq may grant up to 180 calendar days (until February 17, 2025) to regain compliance. The company attributes the delays to significant events and transactions in 2024 and expects to resume normal filing schedules in 2025.
B. Riley Financial and Oaktree Capital Management announced the launch of Great American Group as an independent business following their partnership formation. B. Riley received approximately $203 million in cash, Class B Preferred Units with an initial liquidation preference of about $183 million, and Class A Common Units representing roughly 47% of total outstanding common units. The company expects to record a $235 million gain on this investment in Q4 2024. The transaction allows B. Riley to reduce its debt while maintaining significant equity in the business.